SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Medbox Inc (OTCMKTS:MDBX) a provider of consulting and technology solutions to the booming marijuana industry, disclosed that it appointed Jeff Goh as COO of the company, effective immediately. He possesses years of success in the role of a business leader active in fast growing sectors in technology, food and international business.

The experience

Goh, who is 51, extends three decades of his experience. He has served on various executive management roles for Fortune 500 companies, including Procter & Gamble Co (NYSE:PG) and PepsiCo, Inc. (NYSE:PEP). He has extensive experience on executing scale business models in order to boost profitability, enhance brand identity, and support research and development activities.

Track record

Ambassador Ned L. Siegel, the Chairman of Medbox said that Goh’s track record and impressive background will serve the company well during ongoing pivotal stage of growth. The management welcomes Goh to the team and expects him to lead in a new era for the company. The experience will help the company to become a pioneer firm in the burgeoning marijuana industry. Before joining Medbox, Goh was associated with Corazonas Foods as the CEO of company.

The view

Expressing his views on the new role, Goh said that Medbox is well positioned to serve as the leading consulting services and technology provider. It is well poised to become a known name among the dispensaries and cultivation facilities across the U.S. as legalization expands and entrepreneurs look out for associates to help them in their operations. He added that in his new role, he is committed to ensure the company is operating efficiently, delivering results and recording excellence. The objective is to offer superior service to customers, and aggressively identify new opportunities to execute the solutions.

In last trading session, the stock price of Medbox gained more than 1% to close the trading session at $1.11.